Dragonboat Biopharmaceutical Company

Company snapshot

Dragonboat Biopharmaceutical Company is a biotech organization headquartered in CN. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 1 (1).

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Dragonboat Biopharmaceutical Company. Not investment advice.

• What is Dragonboat Biopharmaceutical Company?

  Dragonboat Biopharmaceutical Company is a biotech organization headquartered in CN. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 1 (1).

• Is Dragonboat Biopharmaceutical Company publicly traded?

  Dragonboat Biopharmaceutical Company appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Dragonboat Biopharmaceutical Company develop or market?

  We link 3 drug profile(s) where Dragonboat Biopharmaceutical Company is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/dragonboat-biopharmaceutical-company-limited#company-drugs.

• What are the latest developments for Dragonboat Biopharmaceutical Company?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Dragonboat Biopharmaceutical Company focus on?

  No specific therapeutic focus areas are currently identified for Dragonboat Biopharmaceutical Company in our database.